India, Nov. 11 -- Several healthcare stocks moved higher following strong quarterly results, improved financial outlooks and clinical and regulatory updates. KORU Medical Systems and Carlsmed raised their full-year revenue guidance, Azenta issued its fiscal 2027 outlook, and Capricor Therapeutics reported progress in the FDA review of its investigational Duchenne muscular dystrophy therapy.
Read on.....
KORU Medical Systems, Inc. (KRMD)
Shares surged 24% after KORU Medical Systems reported third-quarter 2026 revenue growth of 11.2% to $11.6 million from $10.4 million a year earlier. Gross profit increased 20.5% to $7.5 million, while gross margin improved to 65.2% from 60.2%. The company reported net income of $0.2 million, compared with...